The largest database of trusted experimental protocols
> Living Beings > Population Group > West African People

West African People

The West African people are an ethnic group indigenous to the western region of Africa.
They are known for their diverse cultures, languages, and traditions, spanning countries such as Nigeria, Ghana, Senegal, and Liberia.
This population exhibits a rich heritage, including vibrant music, art, and cuisine.
Researchers studying West African populations may leverage PubCompare.ai to optimize research protocols, locating the most accurate and reproducible methods from literature, preprints, and patents.
This powerful AI-driven tool can enhance the efficacy and reproducibility of studies focused on this fasinating region and its people.

Most cited protocols related to «West African People»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2016
2',5'-oligoadenylate Alleles Cell Lines DNA Library Europeans External Lateral Ligament Genome Oligonucleotides RNA-Seq West African People
The individuals used in these studies include those from the HGDP, HapMap, the New York Cancer Project (NYCP) [6 (link)] and samples collected in the United States (Houston, Sacramento), Guatemala, Peru, Sweden. and West Africa. For the HGDP and HapMap the genotypes were available from online databases. For the other sample sets the genotyping was performed at Feinstein Institute for Medical Research (North Shore LIJ Health System) using Illumina 300 K array or using TaqMan assays as previously described [4 (link)]. Of the total of 1620 individual participant genotypes, 825 were included in our previous studies[4 (link)].
The previous genotypes included those from 128 European Americans, 88 African Americans, 60 CEPH Europeans (CEU), 56 Yoruban sub-Saharan Africans (YRI), 19 Bini sub-Saharan Africans, 23 Kanuri West Africans, 50 Mayan Amerindians, 26 Quechuan Amerindians, 29 Nahua Amerindians, 40 Mexican Americans (MAM), 26 Mexicans from Mexico City, 28 Puerto Rican Americans, 43 Chinese (CHB), 43 Chinese Americans, 43 Japanese (JPT), 3 Japanese Americans, 8 Vietnamese Americans, 1 Korean American, 45 Filipino Americans, 2 unspecified East Asian Americans, and 64 South Asian Indian Americans. The Maya-Kachiquel were Maya from the Kachiquel language group as previously described[7 (link)] and is from a collection distinct from the HGDP Maya group.
The additional subject sets in the current study included the following HGDP genotypes: Adygei (also known as Adyghe)(14 individuals), Balochi (15), Bantu from Kenya (12), Bantu from South Africa (8), Basque (13), Bedouin (47), Biaki Pygmy (32), Burusho (7), Cambodian (10), Columbian (7), Daur (10), Druze (43), Kalash (18), Lahu (8), Mandenka (24), Maya (13), Mbuti Pygmy (15), Melanesian (17), Mongolian (9), Mozabite (30), Palestinian (26), Papuan (16), Pima (11), Russian (13), San (7), Uygur (10), Yakut (15), Yi (10), and Yoruba (25). Other additional samples not previously studied included Ashkenazi Jewish (40), Swedish (40), Irish (40) and other European Americans (190) from the NYCP. Genotypes from the HGDP subjects were obtained from the NIH Laboratory of Neurogenetics .
For all subjects, blood cell samples were obtained according to protocols and informed-consent procedures approved by institutional review boards, and were labeled with an anonymous code number linked only to demographic information.
Full text: Click here
Publication 2009
African American Asian Americans Asian Indian Americans Bedouins Biological Assay Blood Cells Cambodians Chinese Chinese Americans East Asian People Ethics Committees, Research Europeans Genotype HapMap Japanese Japanese Americans Korean Americans Malignant Neoplasms Melanesians Mexican Americans Neurogenesis Palestinians Potassium Iodide Puerto Ricans Sub-Saharan African People Vietnamese Americans West African People
Anopheles gambiae samples were collected from 19 sites in 11 west and west-central African countries, between 1998 and 2006. For Kedougou (Senegal), two samples were analysed, collected in 2001 and 2005, respectively. Table 1 shows the sampling sites (listed from west to east and north to south), their geographical coordinates, dates and methods of collection, the ecology of the sampling sites and the total number of M and S molecular forms analysed for kdr genotype.
Full text: Click here
Publication 2008
Anopheles gambiae Genotype West African People
A fingerprint database for the 96 retained microsatellite loci is available for all individuals (1236) with fewer than 5% (average for the database 2.7%) missing data at http://www.ars.usda.gov/Research/docs.htm?docid=16432.
The 952 individuals retained after the removal of the off-types are clones, i.e. vegetatively propagated genotypes. These genotypes were collected as budwood or seeds during various collecting trips, or were selected from cultivated material (“cultivars”), and originate from 12 countries. Wild or primitive (i.e. cultivated on a small scale, and whose origin is local or geographically rather close) germplasm has been collected from 1937 to 2005, in numerous collecting trips in Brazil, Colombia, Ecuador, Peru, French Guiana and Central America [see [15] for a review, and [35] ]. A great part of the wild or primitive material studied originates from Peru (416 clones, 44% of the total), where the species' putative center of origin is located. Other major contributions are from Brazil (248 clones, 26%) and Ecuador (172 clones, 18%), but these also include cultivated clones. These cultivated clones belong to the traditional cultivars named Criollo, Amelonado and Nacional, whose wild origins are poorly known. Criollos from Central America, true “West African Amelonado” from Ghana, a Matina clone from Costa Rica, several Común clones from Brazil and Nacional clones from the Pacific coast of Ecuador were included to study their relatedness to wild or primitive genotypes. Some Amelonado selections (for example, EEG and SIC clone series from Brazil) were also included, but all Trinitario and Trinitario×Amazonians clones, representing human created hybrids between traditional groups Criollo and Amelonado and Trinitario×wild genotypes from the Amazon basin were excluded. Table S3 lists the 952 clones, with their name, lab sample id, passport data (approximate longitude and latitude of collection, country of origin, cluster and subcluster to which they belong with their respective coefficient of membership). Table S3 was established after the International Cocoa Germplasm Database [35] , and after [6] (link), [11] , [29] , [36] –[40] .
Full text: Click here
Publication 2008
Cacao Clone Cells Genotype Homo sapiens Hybrids Plant Embryos Short Tandem Repeat West African People
We developed a decision tree that begins with ambulatory patients presenting with fever to health facilities in rural sub-Saharan Africa (Fig. 1, Fig. 2, Fig. 3, Fig. 4), and proceeds through diagnosis and treatment to disease outcomes according to the sensitivity and specificity of each diagnostic strategy, the patient's age and malaria prevalence among patients. Typical facilities would include health centres and dispensaries staffed by nurses and perhaps clinical officers, and outpatient departments of district hospitals. Once given first-line treatment, patients were assumed to face the same probabilities, health outcomes and costs regardless of diagnostic method. Parameter estimates for initial diagnosis and treatment were extracted from recently published data. Parameters describing treatment seeking patterns, costs for programme implementation and secondary treatment, and duration of disease were based mainly on those used in previous models.12 ,13 (link) Expert opinion was relied on for probabilities of disease progression and mortality without appropriate treatment where reliable published data do not exist. Parameter values, sources, best estimates and probability distributions representing parameter uncertainty are available at: http://www.wpro.who.int/sites/rdt.
We assumed that health workers used the diagnostic test result in their clinical decision-making and that patients diagnosed positive for malaria received ACT and patients negative for malaria received an antibiotic such as amoxicillin. The proportion receiving antibiotics was varied in the sensitivity analysis. Best (most likely) estimates for drug efficacy were set at 85% for ACT in cases of malaria and 75% for antibiotics in bacterial disease. We assumed that antibiotics were not efficacious for malaria or viral illness, and that antimalarials did not cure bacterial disease. We assumed no coinfection between malaria and bacterial infections. Presumptive treatment on the basis of a history of fever was assumed to have perfect sensitivity and zero specificity. For RDTs we assumed a test detecting histidine-rich protein-2 (HRP-2) specific for P. falciparum, as 90% of malaria in sub-Saharan Africa is P. falciparum, with best estimates for RDT sensitivity and specificity of 96% and 95%, respectively.14 (link)-19 Microscopic diagnosis was based on best standard practice of district-hospital and health-centre general laboratories in sub-Saharan Africa, and assumed best estimates for sensitivity and specificity of 82% and 85%, respectively.20 (link),21 (link) We made comparisons according to all possible levels of endemicity of malaria expressed in terms of prevalence of parasitaemia in febrile outpatients presenting at facilities.
The chances of a febrile episode being fatal are far higher if associated with HIV infection.9 (link),22 (link),23 (link) Very high HIV prevalence would affect the decision tree parameters. To avoid a very complex decision tree structure, parameter values were set assuming that HIV prevalence was relatively low (about 10% of people five years old or over), which is typical outside southern Africa.
We calculated the incremental cost in US dollars (2002 prices) of changing from one diagnostic approach to another from the joint perspective of providers and patients, using the ingredients approach to calculate diagnosis costs, first-line drug costs and variable costs of second-line treatment.24 The costs of microscopy diagnosis included materials, staff time, training and supervision. RDT diagnosis included the unit cost of the test; diagnosis according to presumptive treatment was assumed to cost nothing. We assumed drug cost per adult dose to be US$ 1–2.4 for ACT and US$ 0.61–0.93 for antibiotics. We set the cost of RDT kits at US$ 0.6–1 and that of microscopy at US$ 0.32–1.27. Microscopy costs are dependent on workload and were based on a range of 1000 to 6800 or more diagnoses per year. For simplicity we assumed that microscopy was used only for malaria diagnosis, not for other diseases. All other costs of first-line treatment were excluded as they were assumed to be the same across diagnostic strategies. We included variable costs to providers and patients of any second-line treatment (drugs, reagents, food), but excluded fixed costs (buildings, equipment, supervision and most staff costs) as these would not change with numbers of patients. We assumed that unresolved uncomplicated malaria was treated with a second-line drug of the same price and efficacy as the first-line antimalarial. We assumed that secondary treatment for severe bacterial infection was an alternative antibiotic costing twice as much as first-line treatment. Costs associated with the management of neurological sequelae were excluded.
We measured health outcomes in terms of disability-adjusted life years (DALYs) averted, calculated according to the methods of Lopez et al. without age weights.25 We based life expectancies on a west African life table with a life expectancy at birth of 50 years.
The causes of non-malarial febrile infection vary from region to region and encompass diseases such as acute respiratory infections and bacterial meningitis. For simplicity, disability weights and durations for uncomplicated and severe non-malarial febrile illnesses were assumed to be the same as those for malaria. We assumed that bacterial illness was more likely than malaria to become severe, but that only 5–15% of these infections had bacterial causes, with the rest being self-limiting viral infections.
We did probabilistic sensitivity analysis with Monte-Carlo simulations (Palisade@Risk add-in tool to Microsoft Excel), and cost and health outcomes were generated stochastically (10 000 simulations). Policy-makers will wish to identify interventions that are less costly than the comparator and have better health outcomes, called dominant, and rule out those that are more costly and less effective, termed dominated. More costly and more effective interventions may be selected if they are thought to be good value for money. An intervention was defined as cost-effective if it was dominant or had an incremental cost per DALY averted under US$ 150. The value of US$ 150 was chosen in the base case, to represent a decision-maker's valuation of a healthy year of life. This was based on recommendations of the Ad Hoc Committee on Health Research Priorities, which stated that any intervention costing less than US$ 150 per DALY averted should be considered attractive in low-income countries.26
Additional sensitivity analyses were done by varying the parameter of interest and malaria prevalence according to the ranges in Table 1. A full report of all results is available at: http://www.wpro.who.int/sites/rdt, where customized results specific to local settings can be generated online using an interactive model.
Publication 2008
Acute Disease Adult Amoxicillin Antibiotics Antimalarials Bacteria Bacterial Infections Coinfection Diagnosis Disabled Persons Disease Progression Face Fever Food Health Personnel Histidine Hypersensitivity Infection Joints Malaria Meningitis, Bacterial Microscopy Nurses Origin of Life Outpatients Parasitemia Patients Pharmaceutical Preparations Policy Makers Proteins Respiratory Tract Infections sequels Supervision Virus Diseases West African People

Most recents protocols related to «West African People»

Example 1

The present example described the preparation of an HMG glucoside for use in a flavor composition through the hydrolysis of cocoa bean liquor made from West African cocoa beans.

Reagents: A solution of 4N HCl was prepared by adding 100 mL 34-37% HCl in a 250 mL volumetric flask and filling it with water. A solution of 4N NaOH was prepared by dissolving 80 g NaOH pellets in 500 mL of water in a volumetric flask.

Method: Cocoa liquor was run through a sieve and 30.09 g of fine powder was weighed into a 500 mL 3-neck round-bottom flask. The liquor was dissolved in 4N HCl (200 mL) and a stir bar was added to the flask. The sample was stirred at room temperature until the liquor was fully dispersed and flowed freely. A condenser was affixed to the flask and held at 8° C. A digital thermometer was pierced through a rubber stopper to measure the temperature of the solution. The third neck was plugged with a rubber stopper. The flask was wrapped in aluminum foil and heated to approximately 106° C. using a heating mantle. The sample was refluxed for 4.5 hours and left to cool to room temperature. The sample was transferred to a 1 L beaker and neutralized to pH 7 with 4N NaOH using a digital pH meter (pH 6.98 @29° C.). The sample was divided equally into 4 250 mL centrifuge tubes and centrifuged for 10 minutes @ 4500 rpm. The supernatant was filtered under vacuum through a Buchner funnel. The filtrate was then transferred to 2 32 oz plastic containers and lyophilized (yield 52.50 g).

1. Hydrolysis of Cocoa Powder

    • Preparation: A solution of 4N HCl was prepared by adding 100 mL 34-37% HCl in a 250 mL volumetric flask and filling it to the line with water. A solution of 4N NaOH was prepared by dissolving 80 g NaOH pellets in 500 mL of water in a volumetric flask.
    • Procedure: Cocoa liquor made from Theobroma cacao cocoa beans was run through a sieve and 30.09 g of fine powder was weighed into a 500 mL 3-neck round-bottom flask. The liquor was dissolved in 4N HCl (200 mL) and a stir bar was added to the flask. The sample was stirred at room temperature until the liquor was fully dispersed and flowed freely. A condenser was affixed to the flask and held at 8° C. A digital thermometer was pierced through a rubber stopper to measure the temperature of the solution. The third neck was plugged with a rubber stopper. The flask was wrapped in aluminum foil and heated to approximately 106° C. using a heating mantle. The sample was refluxed for 4.5 hours and left to cool to room temperature. The sample was transferred to a 1 L beaker and neutralized to pH 7 with 4N NaOH using a digital pH meter (pH 6.98 @ 29° C.). The sample was divided equally into 4 250 mL centrifuge tubes and centrifuged for 10 minutes @ 4500 rpm. The supernatant was filtered under vacuum through a Buchner funnel. The filtrate was then transferred to 2 32 oz plastic containers and lyophilized.

2. Ethanol Extraction of Hydrolyzed Cocoa Powder

    • The hydrolyzed cocoa powder was extracted with ethanol to remove a bulk of the salts generated during neutralization. Hydrolyzed cocoa powder (50.36 g) was divided equally into 2 500 mL centrifuge tubes. Ethanol (200 mL) was added slowly to each tube as to not disturb the sample. The samples were shaken for 15 minutes on an autoshaker and then centrifuged for 10 minutes @4500 rpm. The supernatant was decanted into a 1000 mL round-bottom flask. The residue was scraped off the bottom of the tubes and redissolved in ethanol (200 mL each). The samples were shaken for 15 minutes on an autoshaker and then centrifuged for 10 minutes @ 4500 rpm. The supernatant was combined with the previous supernatant and evaporated under reduced pressure to remove all organic solvent. The remaining solids were redissolved in approximately 100 mL deionized water and lyophilized.

3. SPE (Solid Phase Extraction) Fractionation of HCP (Hydrolysed Cocoa Powder) Ethanol Extract

    • The extract previously obtained was further fractionated to exhaustively remove the salts and hydrophilic molecules. HCP ethanol extract was transferred to 14 glass vials (approximately 0.5 g each, 20 mL volume) and dissolved in DI water (10 mL). The samples were shaken until dissolved (approximately 1 minute). The samples were filtered through a syringe and PTFE filter to remove particulates as necessary. A solid phase extraction (SPE) cartridge (20 g/60 mL, C18 stationary phase) was conditioned sequentially with DI water (100 mL), methanol (100 mL), and DI water (100 mL). The sample (10 mL) was then loaded onto cartridge and washed with DI water (100 mL) and extracted with methanol (100 mL). The cartridge was reconditioned and the remaining 13 samples were washed and extracted as previously described. The organic solutions were combined and rotary evaporated under reduced pressure. The residue was redissolved in DI water and lyophilized using a Labconco freeze dryer. The sample was separated by high-performance liquid chromatography (HPLC) to narrow down the taste-active molecules of interest.

1. Liquid/Solid Extraction of Liquor

    • Cocoa Liquor made from cocoa beans sourced from Papua New Guinea (PNG liquor) (600 g) was frozen in liquid nitrogen and ground into a fine powder with a laboratory mill. The powder was divided equally into six plastic centrifuge tubes (500 mL volume). Each sample (100 g PNG liquor) was extracted with diethyl ether (200 mL) for 15 minutes using an autoshaker to remove the fat. After centrifugation (10 min, 4500 rpm), the supernatant was discarded. The extraction process was repeated three more times for a total of four times. The remaining defatted liquor was left to air dry in a fume hood overnight. Defatted liquor (200 g) was divided equally between four plastic centrifuge bottles (250 mL volume). To each sample (50 g defatted PNG liquor), 150 mL 70:30 acetone:water was added. The bottles were placed on an autoshaker for 15 minutes. Each sample was centrifuged (5 min, 3500 rpm) and then the supernatant was vacuum filtered using Whatman 540 filter paper and a Buchner funnel. The residue was freed from the bottom of the bottles by hand and additional 70:30 acetone:water (100 mL) was added to each sample. The samples were shaken for 15 minutes using an auto-shaker. After centrifugation (10 min, 4500 rpm), the supernatant was vacuum filtered again using the same procedure described above. The supernatants from each extraction were combined (˜800 mL) and the residue was discarded. The supernatant was rotary evaporated under reduced pressure and the remaining aqueous solution (˜250 mL) was transferred into a separatory funnel (1000 mL volume). The aqueous solution was washed with Dichloromethane (3×300 mL) to remove any xanthines. The dichloromethane layer was discarded, then the aqueous solution was washed sequentially with n-butyl acetate (3×300 mL), ethyl acetate (3×300 mL), and methyl acetate (3×300 mL) to remove procyanidins. The organic layers were discarded and the aqueous solution (F7) was rotary evaporated under reduced pressure to remove any remaining solvent. The remaining water solution was lyophilized using a Labconco freeze dryer (100×103 mbar, −40° C.). Sensory analysis was performed and the savory attribute was found to be in F7.

2. Solid Phase Extraction (SPE)

    • For removal of any residual salts, treated PNG liquor powder (F7) was transferred to 14 glass vials (20 mL volume, approximately 0.5 g sample in each vial) and dissolved in DI water (10 mL). The samples were shaken until dissolved (approximately 1 minute). A solid phase extraction (SPE) cartridge (20 g/60 mL, C18 stationary phase) was conditioned sequentially with DI water (100 mL), methanol (100 mL), and DI water (100 mL). The vacuum was broken and the sample (10 mL) was then loaded onto cartridge. The vacuum was resumed and the sample was washed with DI water (100 mL). The receptacle flask was changed and the sample was extracted with methanol (100 mL). The cartridge was reconditioned and the remaining 13 samples were washed and extracted as previously described. The organic solutions were combined and rotary evaporated under reduced pressure. The residue was redissolved in DI water and lyophilized using a Labconco freeze dryer (100×103 mbar, −40° C.). Sensory analysis confirmed the presence of the savory attribute in the organic fraction.

Full text: Click here
Patent 2024
Acetone Aluminum Amniotic Fluid ARID1A protein, human butyl acetate Cacao Centrifugation Cocoa Powder Dietary Fiber Ethanol ethyl acetate Ethyl Ether Flavor Enhancers Fractionation, Chemical Freezing Glucosides High-Performance Liquid Chromatographies HMGB Proteins Hydrolysis Methanol methyl acetate Methylene Chloride Neck Nitrogen Pellets, Drug Polytetrafluoroethylene Powder Pressure Procyanidins Rubber Salts Savory Solid Phase Extraction Solvents Syringes Taste Thermometers Vacuum West African People Xanthines
The scope of analysis included USAID-supported MDA campaigns in nine West African countries and Cameroon from 2007 to 2020 (Table 2). The sample included 3,880 USAID-supported MDA campaigns across 647 districts and 102 regions within the 10 countries studied (Fig 1), as defined by June 2021 geographic listings. Each district conducted between 1 and 12 MDA rounds (mean 3.94; SD 2.31). Epidemiological coverage averaged 72.6% (SD 14.0). The MDAs detailed in Table 2 are considered district-specific events. Because Table 2 data reflect redistricting (i.e., reclassifying historical data in terms of 2021 district boundaries maintained within the USAID NTD database) and the exclusion of non-USAID supported MDAs, totals may differ from country- or WHO-maintained data sources. Table 2 is presented as a research sample description and not an authoritative record of country LF MDA history. Across all years, MDA implementation favored the months of April, May, June, and July, together accounting for 61.7% of all implemented MDAs. MDAs were implemented the least frequently in the month of October (2.4% of MDAs) likely due to MoH preference and the transition of the USAID fiscal year.
Full text: Click here
Publication 2023
3,4-Methylenedioxyamphetamine IL24 protein, human SD 31 West African People

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
butocin Forests Humidity Trees West African People
The study was conducted in Guinea, a West African country with a population of approximately 13 million, 84% of whom live in rural areas.48 The Guinean health system has three levels—local (38 health districts)—intermediate (eight health regions)—and central (MoH).49 The structural organisation of the central level includes the National Agency for Health Security (ANSS), as an attached service. The ANSS, created on 4 July 2016 by presidential decree (N°:D/2016, 205/PRG/SGG)50 after the EVD outbreak, is in charge of the prevention, surveillance and management of epidemic diseases in Guinea. It implements the strategic orientations of the MoH in terms of health security in the country.
Between 2014 and 2021, Guinea experienced several outbreaks such as EVD, Meningitis, Measles, Yellow Fever, COVID-19, cVDPV2, Lassa Fever and Marburg virus disease. Some of these outbreaks spread over all the health districts, and others affected only one or some health districts, as mapped in figure 1 using the quantum geographic information system version 3.6. The two haemorrhagic fevers (EVD and Marburg virus disease) originated from the N’Zérékoré health region, where there exist two forests (Ziama and Diécké) considered among the world’s last remaining primary forests.51 (link)
Publication 2023
COVID 19 Disease Management Disease Outbreaks Epidemics Forests Hemorrhagic Fevers, Viral Lassa Fever Marburg Virus Disease Measles Meningitis Mental Orientation Morphogenesis Nervous System, Autonomic Secure resin cement West African People Yellow Fever
After university research ethics board clearance was obtained, we recruited dance instructors by sharing a recruitment poster directly with contacts from the dance community (e.g., dance studios, dance apparel stores, community centers offering dance classes), by posting on relevant social media (e.g., dance community Facebook groups), and through word of mouth. The primary investigator provided interested dance instructors with an information letter that outlined what was involved with the study. Then, the primary investigator determined their eligibility through a consultation on a secured virtual meeting platform (i.e., Lifesize). During the virtual consultation, the primary investigator verified the following eligibility requirements: (1) self-reported experience (past or current) teaching dance (any form, any level); (2) no previous training in behavioral coaching methods (in which the foundation of the method was in applied behavior analysis) for dance instruction; and (3) access to an electronic device (computer or tablet preferred) with an Internet connection. If eligible, the primary investigator then reviewed the consent form with the dance instructor during the virtual meeting.
Five female dance instructors from various geographical locations (four from Ontario, Canada and one from the Caribbean) provided informed consent to participate in the study. Dance instructors ranged in age from 28 to 50 years (M = 39; SD = 7.4) and all had over 10 years of experience teaching dance at a private dance studio and/or community dance program. See Table 1 for individual demographic information and a description of each dance instructor’s teaching experience.

Dance instructor demographics and description of teaching experience

ParticipantParticipantCharacteristics(age, sex, ethnicity, education)GeographicLocationSummary of Teaching Experience
Dance Instructor 1

50

Female

White—European

College

Southeastern OntarioTaught children, youth, adults, and seniors at a private dance studio for over 10 years. Registered Royal Academy of Dance teacher, who specialized in teaching recreational and competitive Ballet. Obtained eight teaching certificates (e.g., Classical Ballet Checchetti Method, Modern Theatre Dance).

Dance Instructor

2

39

Female

White—North American

College

East Central OntarioTaught recreational and competitive jazz, and musical theatre to children, youth, and adults for 18 years in a private studio and community dance program. Attended trainings with the National Ballet School of Canada, Broadway Dance Centre in New York, Acro Dance, and Toronto Dance Expo.

Dance Instructor

3

43

Female

White—North American

College

Southwestern OntarioArtistic director/owner of a private dance studio that offered classes in ballet, tap, jazz, acrobatics, musical theatre, lyrical, and hip hop. Had taught recreational and competitive dance to children, youth, and adults for over 10 years. Completed Associated Dance Arts of Professional Teachers training, Level 2 Progressive Ballet Technique, and Level 2 Acro Dance Teacher’s Association.

Dance Instructor

4

28

Female

White—North American

Undergraduate (with minor in Dance)

Southwestern OntarioTaught children, youth, and adults recreational and/or competitive ballet, tap, jazz, lyrical, musical theatre, and hip hop for over 10 years.

Dance Instructor

5

35

Female

Black—Caribbean

Undergraduate (in Performing Arts, Major in Dance

CaribbeanTaught recreational and professional level modern and West African dance forms to children, youth, and adults for 20 years.
We conducted all sessions remotely across two sites using Lifesize—a secure videoconferencing platform compliant with local privacy legislation. The trainer delivered training from their home and the dance instructors received training from their respective homes. Each session was recorded using the built-in capabilities of the Lifesize platform. At the start of each session, we provided dance instructors with a word document that contained a blank table with four columns—one for each strategy in the behavioral coaching package and 10 rows with a note that stipulated that those rows could be added or removed as needed. During sessions, the dance instructor used the word document to record their implementation of the behavioral coaching strategies. As a reference tool, the trainer had access to sample templates (completed word documents) for each dance skill during training sessions. The trainer screen shared these sample templates with the dance instructor only during an error correction procedure.
During sessions, the trainer and dance instructor reviewed: (1) an online instruction manual (a PowerPoint presentation that provided key points on how to implement each strategy on each slide, a full description of these key points in the notes section for each slide, and an example of how to implement each strategy); (2) a tip sheet that concisely reviewed the material covered in the online instructional manual; and (3) sample videos of a dancer performing dance skills correctly and incorrectly (with planned errors commonly observed in the dance studio setting by the first author). The trainer controlled the dance instructor’s access to the sample dancer videos and screen shared the video with the dance instructor when appropriate.
Publication 2023
Adult Applied Behavior Analysis Caribbean People Child Eligibility Determination Ethnicity Medical Devices Oral Cavity Tablet Teaching West African People Woman Youth

Top products related to «West African People»

The Lenovo Tab M10 FHD Plus is a tablet designed for versatile use. It features a 10.3-inch Full HD+ display with a resolution of 1920 x 1200 pixels. The tablet is powered by a MediaTek Helio P22T octa-core processor and comes with up to 4GB of RAM and 128GB of internal storage. It runs on the Android operating system.
Sourced in United States
The Ion Torrent S5 is a next-generation sequencing system designed for a variety of applications, including gene expression analysis, targeted sequencing, and small genome sequencing. The system utilizes semiconductor-based sequencing technology to generate DNA sequence data.
Mectizan is a laboratory-tested product developed by the Merck Group. It is designed to facilitate the analysis and experimentation processes within scientific research settings. The core function of Mectizan is to provide a reliable and consistent tool for researchers and laboratory technicians to carry out their work effectively.
Sourced in United States, United Kingdom
Oleic acid-albumin-dextrose-catalase (OADC) is a complex growth supplement used in microbiological culture media. It contains oleic acid, albumin, dextrose, and catalase, which provide nutrients and growth factors to support the cultivation of certain microorganisms, particularly mycobacteria.
Sourced in Germany, United States, United Kingdom
The AVE buffer is a component of Qiagen's nucleic acid extraction kits. Its core function is to provide a medium for the efficient lysis and inactivation of samples, allowing the subsequent purification of nucleic acids.
Sourced in Germany
The QIAamp DNA Mini Kit 50 is a DNA extraction and purification kit designed for the isolation of genomic DNA from a variety of sample types, including blood, tissue, and cells. The kit utilizes a silica-based membrane technology to efficiently capture and purify DNA, making it suitable for downstream applications such as PCR, sequencing, and other molecular biology techniques.
Sourced in United States, United Kingdom, Germany, Australia, Japan, Switzerland, Italy, China, Canada, France
Penicillin and streptomycin are antibacterial agents used in laboratory settings. Penicillin is a beta-lactam antibiotic that inhibits the synthesis of the bacterial cell wall, while streptomycin is an aminoglycoside antibiotic that disrupts protein synthesis in bacteria. These two compounds are commonly used together as a broad-spectrum antimicrobial solution for various laboratory applications.
Sourced in United States, Germany, United Kingdom, Italy, Brazil
The PureLink Genomic DNA Kit is a laboratory equipment product designed for the rapid and efficient extraction and purification of genomic DNA from a variety of sample types. It utilizes a spin column-based method to isolate high-quality DNA that can be used in various downstream applications.
Sourced in United States
The Omni 2.5 array is a high-density genotyping microarray platform developed by Illumina. It is designed to detect and analyze genetic variations across the human genome. The core function of the Omni 2.5 array is to provide comprehensive genomic coverage and enable the identification of genetic markers associated with various traits and diseases.

More about "West African People"

The West African people are an indigenous ethnic group from the western region of Africa, known for their diverse cultures, languages, and traditions.
This fascinating population spans countries like Nigeria, Ghana, Senegal, and Liberia, with a rich heritage encompassing vibrant music, art, and cuisine.
Researchers studying West African populations can leverage powerful tools like PubCompare.ai to optimize their research protocols.
This AI-driven platform enables them to locate the most accurate and reproducable methods from literature, preprints, and patents, enhancing the efficacy and reproducibility of their studies.
When conducting research on West African populations, scientists may utilize a variety of specialized equipment and techniques.
For example, the Tab M10 FHD Plus, Ion Torrent S5, and QIAamp DNA Mini Kit 50 can be employed for genetic analysis and sequencing.
Mectizan, a drug used to treat onchocerciasis (river blindness), and OADC (Oleic acid-albumin-dextrose-catalase), a growth supplement for mycobacteria, may also be relevant in certain studies.
Additionally, the AVE buffer and Penicillin and streptomycin can be used for sample processing and culturing, while the PureLink Genomic DNA Kit and Omni 2.5 array can facilitate DNA extraction and genotyping.
By leveraging these tools and techniques, along with the insights gained from PubCompare.ai, researchers can optimize their protocols and gain deeper understandings of the West African people and their fascinating cultures.